Report Categories Report Categories

Report Categories

industry Category

All

Total: 3 records, 1 pages

Global Neuroblastoma Treatment Drugs Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

date 09 Jan 2024

date Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

According to our (Global Info Research) latest study, the global Neuroblastoma Treatment Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

Add To Cart

Add To Cart

Global Neuroblastoma Treatment Drugs Supply, Demand and Key Producers, 2023-2029

date 20 Feb 2023

date Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

The global Neuroblastoma Treatment Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

Add To Cart

Add To Cart

Global Neuroblastoma Treatment Drugs Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

date 01 Jan 2023

date Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can range from a painless bump in the abdomen to fevers and limp. Neuroblastoma treatment depends on multiple factors, including the patient's age, whether the tumor has already spread beyond its initial location and the risk of the tumor growing or spreading in the future.

USD3480.00

Add To Cart

Add To Cart

industry 09 Jan 2024

industry Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

According to our (Global Info Research) latest study, the global Neuroblastoma Treatment Drugs market size was valued at USD million in 2023 and is forecast to a readjusted size of USD million by 2030 with a CAGR of % during review period.

USD3480.00

addToCart

Add To Cart

industry 20 Feb 2023

industry Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

The global Neuroblastoma Treatment Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

USD4480.00

addToCart

Add To Cart

industry 01 Jan 2023

industry Pharma & Healthcare

new_biaoQian Neuroblastoma Treatment Drugs

Neuroblastoma (NB) is the most common cancer in childhood and infancy. Most children with neuroblastoma are diagnosed before age 5 and symptoms can range from a painless bump in the abdomen to fevers and limp. Neuroblastoma treatment depends on multiple factors, including the patient's age, whether the tumor has already spread beyond its initial location and the risk of the tumor growing or spreading in the future.

USD3480.00

addToCart

Add To Cart